Achieving durable psoriasis remission with nucleic acid therapeutics

Area of Science:

• Dermatology and Immunology
• Molecular Biology
• Biotechnology

Background:

• Psoriasis is a chronic inflammatory skin disease driven by immune imbalance and rapid skin cell growth.
• Current immunomodulators offer effective treatment but do not address all clinical needs.
• Gene-level modulation offers a precise therapeutic approach for psoriasis.

Purpose of the Study:

• To review the therapeutic potential of nucleic-acid-based therapies for psoriasis.
• To critically examine the challenges associated with these novel therapies.
• To discuss recent advances and future personalized strategies.

Main Methods:

• Literature review of nucleic-acid-based therapies (siRNA, miRNA, oligonucleotides).
• Analysis of challenges including immunogenicity, off-target effects, delivery, and manufacturing.
• Summary of advances in biomaterials for gene modulation.

Main Results:

• Nucleic-acid therapies offer precise gene modulation for psoriasis.
• Key challenges include immunogenicity, off-target effects, delivery, and scalability.
• Biomaterial advancements are improving safety and durability of gene modulation.

Conclusions:

• Nucleic-acid-based therapies represent a promising next generation of psoriasis treatments.
• Overcoming delivery and safety challenges is crucial for clinical translation.
• Personalized strategies using these therapies could complement existing treatments.